Physician profile
Michael Warren
NPI 1093138075
$7,183.94
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $670 · 2021: $1,819 · 2022: $2,529 · 2023: $2,143 · 2024: $23.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,859 · Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,859.33 |
| Food and Beverage | $307.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,835.31 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $1,882.33 | 2022-2023 | Omnia |
| Medical Device Business Services, INC. | $260.00 | 2020 | |
| Alexion Pharmaceuticals, INC. | $207.28 | 2020-2021 | |
| Tersera Therapeutics LLC | $177.00 | 2022 | |
| Abbvie INC. | $140.46 | 2021-2024 | Ubrelvy |
| Boston Scientific Corporation | $139.13 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $77.30 | 2020 | |
| Amgen INC. | $76.16 | 2020-2023 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.43 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $56.44 | 2021 | |
| Medtronic USA, INC. | $51.04 | 2020 | |
| Kyowa Kirin, INC. | $48.61 | 2021 | |
| Sk Life Science, INC. | $39.80 | 2020-2021 | |
| Ucb, INC. | $31.64 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $20.66 | 2021 | |
| Acorda Therapeutics, INC | $20.06 | 2020 | |
| Heron Therapeutics, INC. | $15.84 | 2023 | Zynrelef |
| Jazz Pharmaceuticals INC. | $13.72 | 2020 | |
| Redhill Biopharma INC. | $13.59 | 2020 | |
| Acadia Pharmaceuticals INC | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.